Clinical Trials
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8906
Evaluation of Merbarone in Hepatoma, Phase II
Activated
02-01-1990
Closed
05-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8910
Evaluation of Low Dose Continuous 5-Fluorouracil (5-FU) and Weekly Cis-Platinum (CDDP) in Advanced Adenocarcinoma of the Stomach
Activated
01-15-1990
Closed
08-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8842
Dihydroxyazacytidine in Malignant Mesothelioma, Phase II
Research Committee(s)
Sarcoma
Activated
12-15-1989
Closed
11-15-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8943
Evaluation of Merbarone in Advanced Soft-Tissue Sarcomas
Activated
12-15-1989
Closed
07-01-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8894 (INT-0105) (EST-2889)
A Comparison of Bilateral Orchiectomy with or without Flutamide for the Treatment of Patients with Histologically Confirmed Stage D2 Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
12-15-1989
Closed
09-15-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8917
5-Fluorouracil, Leucovorin and Roferon-A® in Advanced Colorectal Cancer, Phase II Pilot
Activated
12-01-1989
Closed
02-15-1992
Closed
Phase
Accrual
93%
Published
SWOG Clinical Trial Number
SWOG-8903
Phase I Trial of Promace-CytoBOM with GM-CSF for Treatment of Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
11-15-1989
Closed
11-01-1993
Closed
Phase
Accrual
82%
Published
SWOG Clinical Trial Number
SWOG-8828
A Phase II Trial of Carboplatin (CBDCA) in Relapsed or Refractory Acute Myeloid Leukemia
Activated
11-15-1989
Closed
10-15-1992
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
SWOG-8808
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Chronic Myeloid Leukemia
Activated
11-15-1989
Closed
11-15-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8857
Alternating Cisplatin/VP-16 with Continuous CAV and Consolidation Chemoradiotherapy for Extensive Small Cell Lung Cancer with PCI for Complete Responders
Activated
10-15-1989
Closed
05-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8926
Evaluation of Low Dose Continuous Infusion 5-Fluorouracil in Patients with Advanced and Recurrent Renal Cell Carcinoma
Activated
10-01-1989
Closed
02-15-1991
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
SWOG-8999
Evaluation of Radiation Treatment Following Surgical Resection of Solitary Brain Metastasis
Activated
08-15-1989
Closed
12-15-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8905
Phase II/III Study of Fluorouracil (5-FU) and its Modulation in Advanced Colorectal Cancer
Activated
08-01-1989
Closed
01-01-1993
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
SWOG-8912
Evaluation of Fazarabine in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Activated
07-15-1989
Closed
01-01-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8897
Comparison of Adjuvant Chemotherapy With or Without Endocrine Therapy in High-Risk, Node Negative Breast Cancer Patients, and a Natural History Follow-up Study in Low-Risk Node Negative Patients (to initially low risk patients)
Research Committee(s)
Breast Cancer
Activated
07-15-1989
Closed
02-01-1993
Closed
Phase
Accrual
46%
Published
SWOG Clinical Trial Number
SWOG-8907
A Phase ll Trial of Combination Chemotherapy Plus Verapamil in Drug Refractory Intermediate Grade and Selected High Grade Non-Hodgkin's Lymphomas
Activated
07-01-1989
Closed
12-15-1991
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8925
Evaluations of Cisplatin + VP-16 Followed by Mitotane at Progression if No Prior Mitotane or Cisplatin + VP-16 Only if Prior Treatment with Mitotane in Advanced and Metastatic Adrenal Cortical Carcinoma
Research Committee(s)
Genitourinary Cancer
Activated
06-15-1989
Closed
12-01-1995
Closed
Phase
Accrual
50%
SWOG Clinical Trial Number
SWOG-8816
Study of 13-cis Retinoic Acid (Accutane) Plus rIFN-A (Roferon-A) in Mycosis Fungoides
Activated
05-15-1989
Closed
01-01-1993
Closed
Phase
Accrual
71%
Published
SWOG Clinical Trial Number
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)
A Study of Radiotherapy With or Without Concurrent Cisplatin in Patients with Nasopharyngeal Cancer
Research Committee(s)
Head and Neck Cancer
Activated
05-15-1989
Closed
12-01-1995
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8807
An Investigation of the Relationship Between an Integrated, System Education Approach and Breast Self Exam (BSE) Compliance
Research Committee(s)
Breast Cancer
Activated
05-15-1989
Closed
12-01-1993